Tocilizumab in hospitalized patients with COVID-19: Clinical outcomes, inflammatory marker kinetics, safety, and a review of the literature

Joshua A. Hill, Manoj P. Menon, Shireesha Dhanireddy, Mark M. Wurfel, Margaret Green, Rupali Jain, Jeannie D. Chan, Joanne Huang, Danika Bethune, Cameron Turtle, Christine Johnston, Hu Xie, Wendy M. Leisenring, H. Nina Kim, Guang-Shing Cheng
doi: https://doi.org/10.1101/2020.08.05.20169060

Article usage

Article usage: August 2020 to January 2025

AbstractFullPdf
Aug 20209180159
Sep 2020105058
Oct 202083043
Nov 202072028
Dec 202033023
Jan 202154022
Feb 202178016
Mar 202177724
Apr 202186017
May 202198213
Jun 202172011
Jul 202144112
Aug 202137522
Sep 202140713
Oct 202151119
Nov 202151319
Dec 20213328
Jan 20222865
Feb 20222613
Mar 20222113
Apr 20222325
May 202223212
Jun 20222217
Jul 20221603
Aug 20221737
Sep 20223518
Oct 20222016
Nov 20221914
Dec 20222105
Jan 20232933
Feb 20232667
Mar 20231734
Apr 20232517
May 202317414
Jun 20231347
Jul 20231646
Aug 202322157
Sep 20231352
Oct 20231512
Nov 202327135
Dec 20231306
Jan 2024914
Feb 20241223
Mar 202415710
Apr 20242267
May 20241853
Jun 20241118
Jul 20241537
Aug 20241798
Sep 20242535
Oct 202416826
Nov 20241318
Dec 2024925
Jan 2025102
Back to top
Posted August 11, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Tocilizumab in hospitalized patients with COVID-19: Clinical outcomes, inflammatory marker kinetics, safety, and a review of the literature
Joshua A. Hill, Manoj P. Menon, Shireesha Dhanireddy, Mark M. Wurfel, Margaret Green, Rupali Jain, Jeannie D. Chan, Joanne Huang, Danika Bethune, Cameron Turtle, Christine Johnston, Hu Xie, Wendy M. Leisenring, H. Nina Kim, Guang-Shing Cheng
medRxiv 2020.08.05.20169060; doi: https://doi.org/10.1101/2020.08.05.20169060
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area